Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection

  • Yan-Ming Zhou1, 2,
  • Xiao-Feng Zhang2,
  • Bin Li1,
  • Cheng-Jun Sui2 and
  • Jia-Mei Yang2Email author
Contributed equally
BMC Cancer201515:689

https://doi.org/10.1186/s12885-015-1720-0

Received: 28 April 2015

Accepted: 8 October 2015

Published: 14 October 2015

Abstract

Background

Postoperative recurrence remains the major cause of death after curative resection for hepatocellular carcinoma (HCC). This study was conducted to evaluate the impact of postoperative complications on HCC recurrence after curative resection.

Methods

The postoperative outcomes of 274 HCC patients who underwent curative resection were analysed retrospectively.

Results

Of the 247 HCC patients, 103 (37.6 %) patients developed postoperative complications. The occurrence of postoperative complications was found to be associated with a significantly higher tumor recurrence (76.2 % vs. 56.6 %, P = 0.002) and a lower 5-year overall survival rate (27.7 % vs. 42.1 %; P = 0.037) as compared with those without complications. Regarding the recurrence pattern, early recurrence (≤2 years) was more frequently seen in patients with complications than that in patients without complications (54.5 % vs.38.6 %; P = 0.011). Multivariate analysis indicated that postoperative complications occurrence was an independent risk factor for early recurrence (odds ratio [OR] 2.223; 95 % confidence intervals [95 % CI] 1.161–4.258, P = 0.016) and poor overall survival (OR 1.413; 95 % CI, 1.012–1.971, P = 0.042).

Conclusions

The results of the present study indicate that the occurrence of postoperative complications is a predictive factor for HCC recurrence after curative hepatectomy, especially for early recurrence.

Keywords

Hepatocellular carcinomaRecurrenceResectionPostoperative complications

Background

Hepatocellular carcinoma (HCC) is the 5th most common malignancy and ranks the 3rd cause of cancer-related death worldwide. Although hepatic resection is an effective treatment option for HCC, the long-term prognosis remains poor in most series mainly because of the high tumor recurrence in the remnant liver [1].

With improvements in careful patient selection, surgical techniques and perioperative care, hepatectomy for HCC has become a safe procedure with a reported operative mortality rate lower than 5 % at high-volume centers. However, the incidence of complications is as high as 30.9–42.6 % [24]. Several studies have assessed the impact of postoperative complications on long-term survival in patients with HCC [2, 57], but few data are available in the literature regarding its impact on the risk of tumor recurrence. To clarify this issue, we conducted a retrospective study of 274 consecutive patients who underwent curative resection for HCC.

Methods

Patients

Included in this study were 274 consecutive patients who underwent curative resection for HCC at the Department of Special Treatment of the Eastern Hepatobiliary Surgery Hospital affiliated to the Second Military Medical University (Shanghai, China) between January 2004 and September 2008. Curative resection was defined as complete macroscopic removal of the tumor with a microscopic free margin. Patient selection for hepatectomy and details of hepatectomy were as previously reported [8]. A major resection was defined as removal of at least three liver segments, and a minor resection was defined as removal of two or fewer than two segments. Postoperative mortality was defined as any death occurring within 30 days of surgery or within the same hospital stay. Postoperative complications were defined as occurrence of any medical or surgical complication during the hospital stay. Data for long-term outcomes, including overall survival (OS) and recurrence, were obtained by reviewing the medical records at the last follow-up. After surgery, patients were followed-up every 1 month by tumor marker (alpha-fetoprotein, AFP) analysis and ultrasound at least every 3 months in the first year after hepatectomy, and then at gradually increasing intervals. When tumor recurrence or metastases were suspected, further investigations with computed tomography scan, or magnetic resonance imaging were done. Fine needle aspiration/biopsies were done when necessary. Recurrences were divided as early (≤2 years) and late (>2 years) recurrences [9]. This study was approved by the ethics committee of the Second Military Medical University, and all participants provided written informed consent.

Statistical analysis

Categorical and continuous data were compared by the χ2 test and the Student t test, respectively. Overall survival was determined by Kaplan-Meier analysis. The Cox proportional hazard regression model was used to determine the independent risk factors for recurrence and survival as well as complication, based on the variables selected by univariate analysis. All statistical analyses were performed using SPSS for Windows (version 11.0; SPSS Institute, Chicago, IL, USA). P < 0.05 was considered statistically significant.

Results

Patient characteristics

The 274 HCC patients included 253 (92.3 %) men and 21 (7.7 %) woman with a median age of 56 (range 21–87) years. Of them, 103 (37.6 %) developed 169 postoperative complications (Table 1), of which pleural effusion (18.9 %) and ascites (12 %) were the most common complications. One patient died of postoperative sepsis and another one died of postoperative liver failure, giving an overall hospital mortality rate of 0.8 %.
Table 1

Details of postoperative complications

Types of complications

No. of patients (%)

Liver failure/insufficiency

14 (5.1)

Bile leak

5 (1.8)

Biloma/abscess

2 (0.7)

Intra-abdominal infection

5 (1.8)

Hemorrhage

4 (1.5)

Ascites

31 (12)

Wound infection/dehiscence

11 (4)

Pleural effusion

52 (18.9)

Pneumonia

11 (4)

Atelectasis

8 (2.9)

Arrhythmia

7 (2.5)

Heart failure

1 (0..3)

Urinary retention

4 (1.5)

Urinary tract infection

3 (1.1)

Renal insufficiency/failure

3 (1.1)

Ileus

5 (1.8)

Delayed Gastric Emptying

3 (1.1)

The clinicopathological characteristics of the patients with and without postoperative complications are shown in Table 2. The percentages of elderly patients and those with larger tumors were significantly higher in the postoperative complication group than those in the non-complication group. Major resections were performed more frequently in patients with postoperative complications. Similarly, those with postoperative complications had a longer operation time, more intraoperative blood loss and a greater blood transfusion requirement.
Table 2

Comparison of clinicopathological features between patients with or without postoperative complication

Variable

With complications (n = 103)

Without complications (n = 171)

P-value

Sex (male/female)

95/8

158/13

0.960

Age (years)

58.3 ± 11.2

54.7 ± 10.2

< 0.001

Hepatitis B infection

97 (94.2 %)

166 (97.1 %)

0.236

Hepatitis C infection

0

1 (0.6)

0.437

Child-Pugh (A/B)

98/5

168/3

0.140

AFP level > 400 ng/ml

27 (26.2 %)

31 (18.1 %)

0.113

Cirrhosis

41 (39.8 %)

76 (44.4 %)

0.452

Tumor diameter > 5 cm

73 (68.9 %)

77 (51.5 %)

0.005

Tumor number (St/Mt)

85/18

147/24

0.444

Tumor capsule absent

49 (47.6 %)

72 (42.1 %)

0.377

Vascular invasion

53 (51.5 %)

72 (42.1 %)

0.132

Edmondson’s grade (I-II/III-IV)

22/ 81

34/137

0.769

TNM stage (I-II/III)

61/42

115/56

0.179

Operative procedure (MAR/MIR)

59/44

76/95

0.040

Use of the Pringle’s maneuver

97 (94.2 %)

160 (93.6 %)

0.840

Operation time (min)

297 ± 113

256 ± 134

< 0.001

Intraoperative blood loss (ml)

840 ± 520

620 ± 470

< 0.001

Blood transfusion requirement

34 (33 %)

37 (21.6 %)

0.037

St single tumor, Mt multiple tumors, AFP alpha-fetoprotein, MAR major resection, MIR minor resection

Patient recurrence and survival

During a median follow-up period of 38 months, 175 (64.3 %) patients (excluding the hospital deaths) experienced intrahepatic recurrences by the end of the study period. The initial management for the recurrences included transarterial chemoembolization (n = 72), percutaneous ablation (n = 37), repeated resection (n = 28), liver transplantation (n = 3), and conservative treatment (n = 35). The frequency of HCC recurrence was 77 (76.2 %) in patients with postoperative complications and 98 (56.6 %) in those without postoperative complications (P = 0.002). There were 121 early and 54 late recurrences. Early recurrence was more frequently seen in patients with postoperative complications than that in patients without postoperative complications (54.5 % vs.38.6 %; P = 0.011), while late recurrence was similar between the two groups (22.8 % vs.18.1 %; P = 0.354).

Univariate analysis showed that significant risk factors associated with early recurrence were serum AFP > 400 ng/mL, tumor diameter > 5 cm, the absence of tumor capsules, vascular invasion, multiple tumors, an advanced TNM stage, and occurrence of postoperative complications. Multivariate analysis showed that postoperative complications were one of the independent factors (odds ratio [OR] 2.223; 95 % confidence intervals [95 % CI] 1.161-4.258, P = 0.016) (Table 3).
Table 3

Multivariable analysis of risk factors for early recurrence

Variables

Odds ratio

95 % confidence intervals

P-value

Alpha-fetoprotein > 400 ng/mL

1.613

1.101–2.362

0.014

Tumor diameter > 5 cm

1.083

0.736–1.593

0.685

Tumor capsule absent

0.747

0.452–1.235

0.255

Vascular invasion

2.916

1.541–5.516

< 0.001

TNM stage (III)

1.353

0.962–1.902

0.082

Multiple tumors

1.204

1.011–1.433

0.037

Postoperative complications

2.223

1.161–4.258

0.016

The 5-year OS for the entire cohort of HCC patients was 37 %, and the 5-year OS in patients who experienced postoperative complications was significantly lower than that in patients without complications (27.7 % vs. 42.1 %; P = 0.037) (Fig. 1). Multivariate analysis demonstrated that cirrhosis (OR 1.544; 95 % CI 1.051–2.269, P = 0.027), vascular invasion (OR 2.712; 95 % CI, 1.371–5.364, P = 0.004), and postoperative complications (OR 1.413; 95 % CI, 1.012–1.971, P = 0.042) were significant independent risk factors for decreased OS.
Fig. 1

Cumulative overall survival after surgical resection in patients with and without postoperative complications

Risk factor for postoperative complications

Univariate analysis showed that old age (≥70 years), major resections, large tumor, blood transfusion, operating time ≥ 300 min, and intraoperative blood loss ≥1000 ml were associated with the occurrence of postoperative complications. Multivariate analysis identified two independent risks for complications occurrence: old age (OR 2.173; 95 % CI, 1.014–4.656, P = 0.046) and intraoperative blood loss ≥1000 ml (OR 1.771; 95 % CI, 1.138–2.756, P = 0.011).

Discussion

Complications after hepatectomy for HCC are common with morbidity rates between 30.9 and 42.6 % [24]. In line with literature, a morbidity rate of 37.6 % was observed in the present study. The most common were ascites or pleural effusion. The high incidence of ascites was probably related to high portal pressure after liver resection, which can trigger massive ascites by stimulating neurohormonal systems to promote renal water and sodium resorption [10]. The changes generated by vascular clamping and instruments working close to the diaphragm during hepatectomy may increase the risk of pleural effusion [11].

There is no doubt that postoperative complications may lead to prolonged hospital stay and higher medical costs. Recent evidence has suggested that postoperative complications also have negative impact on long-term survival in patients with gastric cancer [12], esophageal cancer [13], pancreatic cancer [14], hilar cholangiocarcinoma [15], and colorectal liver metastasis [16, 17]. To the best of our knowledge, there have been four studies on the effect of postoperative complications on the survival and prognosis of HCC patients. In a study of 863 HCC patients undergoing curative resection, Chok et al. [5] found that the presence of postoperative complications was independently associated with poor OS. In another study of 291 patients, Kusano et al. [2] reported that the 5-year OS rate was significantly lower in patients with perioperative complications than that in those without these complications (34.3 % vs.48.7 %). Their multivariate analysis showed that the presence of perioperative complications was an independent predictor of poor OS. A study of 100 patients by Mizuguchi et al. [6], and a study of 376 patients by Okamura et al. [7] also reported the similar results. Consistent with previous investigations, our study reconfirmed the prognostic value of postoperative complications.

Few data are available in the literature regarding the potential impact of complications on HCC recurrence. It was found in this study that postoperative complications were associated with a higher HCC recurrence after hepatectomy, and identified as an independent risk factor for early recurrence. This finding is consistent with the finding of Okamura et al. [7], who reported that the recurrence-free survival curve for patients with postoperative complications was steeper than that for the group without, especially from 12 to 24 months. Early recurrence might reflect residual micrometastasis in the liver [9]. In the field of periampullary cancer surgery, the negative impact of postoperative complications on survival is even more prominent in patients with microscopically residual disease [18]. An explanation for negative impact of postoperative complications on cancer recurrence remains unclear. One possible factor promoting metastatic growth and early recurrence is immunosuppression resulting from systemic inflammatory responses [16]. It has been demonstrated that surgical trauma and septic inflammation may promote T-cell commitment toward a T-helper 2-type lymphocyte pattern [19]. The T-helper 2-type cytokines (interleukin-10 in particular) were shown to down-modulate tumor-specific immune response probably through several mechanisms: (i) directly suppressing interferon γ and interleukin-12 production, thereby preventing the activation of cytotoxic T lymphocytes and natural killer cells; (ii) reducing major histocompatibility complex expression on the surface of tumor cells, thus preventing the optimal expression of binary complexes formed by tumor antigen in association with major histocompatibility complex molecules on the surface of such cells; and (iii) inhibiting tumor antigen presentation by antigen-presenting cells [20]. In fact, serum interleukin-10 level was found to be associated with a worse disease-free survival in patients with resectable HCC [21]. As late recurrence is considered as the most significant factor attributable to hepatitis related multicentric carcinogenesis, it is therefore reasonable to conclude that postoperative complications have no effect on late recurrence.

Conventional aggressive biological behaviors of HCC such as vascular invasion, poor tumor differentiation and multiple tumors have been reported to affect recurrence. Our finding presented additional data that the surgeon’s performance is also an important determinant. Similar to other series [2], our study also found that increased intraoperative blood loss was an independent predictor of complications occurrence after hepatic resection for HCC. Various methods of vascular occlusion (such as Pringle’s maneuver, total or selective hepatic vascular exclusion, combination of Pringle’s maneuver and infrahepatic inferior vena cava clamping, and hanging maneuver) and new surgical devices (such as Harmonic Scalpel, radiofrequency electrodes, and staplers) have been suggested for reducing blood loss during liver parenchymal transaction. Some recent studies [22] have suggested that laparoscopic surgery for HCC can reduce intraoperative blood loss without compromising the oncologic outcome. Hepatic surgeons should know how to use these surgical strategies appropriately according to the actual situation in clinical practice.

Unlike previous findings [7], this study failed to show that the use of Pringle’s maneuver is a risk factor for postoperative complications. The main drawback related to Pringle’s maneuver is the hepatic ischemia-reperfusion injury. However, there is ample evidence that liver parenchyma tolerates prolonged ischemic injury better than the effect of massive bleeding and blood transfusion [23]. More importantly, there is no clinical evidence that Pringle’s maneuver adversely affects the oncologic outcome [24]. To avoid irreversible injury to the liver, Pringle’s maneuver should be done with intermittent clamping with an upper limit of 120 min [23].

It was also found in our study that old age was a significant risk factor for postoperative complications occurrence, probably because elderly patients are more likely to have co-morbidities. This emphasizes the need of multidisciplinary preoperative evaluation and postoperative management of elderly patients undergoing hepatic resection [25].

There are several limitations in this study. First, its retrospective nature may inherently incur selection bias. In addition, as this is a single-center study, the generalizability of our findings awaits further investigation. Finally, the effect of classification of postoperative morbidity by the Clavien-Dindo stratification was not analyzed because of the limited number of patients [26]. Farid et al. [16] reported a negative relationship between postoperative morbidity and the oncologic outcome in 750 patients undergoing hepatic resection for colorectal metastases. Interestingly, the severity of complications was found to be irrelevant to the oncologic outcome. A similar observation was also noted by Correa-Gallego et al. [17]. Therefore, any postoperative complications (even minor ones) need to be prevented for the sake of improving the cancer-specific outcome [17].

Conclusion

The results of the present study indicate that the occurrence of postoperative complications is a predictive factor for HCC recurrence after curative hepatectomy, especially for early recurrence. To improve the patients’ oncological outcome, surgeons should do their best to minimize the occurrence of postoperative complications wherever possible. Further large prospective multicenter clinical trials are necessary to confirm our results.

Notes

Abbreviations

HCC: 

Hepatocellular carcinoma

OR: 

Odds ratio

95 % CI: 

95 % confidence intervals

OS: 

overall survival

TNM: 

Tumor node metastasis

Declarations

Acknowledgements

We thank Dr. Yanfang Zhao (Department of Health Statistics, Second Military Medical University, Shanghai, China) for her critical revision of the statistical analysis section.

Finding sources

This work was supported by the National Nature Science Foundation of Fujian Province of China (Project no. 2014D011 and 2015 J0155).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Hepatobiliary & Pancreatovascular Surgery, First affiliated Hospital of Xiamen University
(2)
Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University

References

  1. Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol. 2010;8:55.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Kusano T, Sasaki A, Kai S, Endo Y, Iwaki K, Shibata K, et al. Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection. Eur J Surg Oncol. 2009;35:1179–85.View ArticlePubMedGoogle Scholar
  3. Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF. Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg. 2011;35:2073–82.View ArticlePubMedGoogle Scholar
  4. Thelen A, Benckert C, Tautenhahn HM, Hau HM, Bartels M, Linnemann J, et al. Liver resection for hepatocellular carcinoma in patients without cirrhosis. Br J Surg. 2013;100:130–7.View ArticlePubMedGoogle Scholar
  5. Chok KS, Ng KK, Poon RT, Lo CM, Fan ST. Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg. 2009;96:81–7.View ArticlePubMedGoogle Scholar
  6. Nagayama M, Meguro M, Shibata T, Kaji S, Nobuoka T, Kimura Y, et al. Prognostic impact of surgical complications and preoperative serum hepatocyte growth factor in hepatocellular carcinoma patients after initial hepatectomy. J Gastrointest Surg. 2009;13:325–33.View ArticlePubMedGoogle Scholar
  7. Okamura Y, Takeda S, Fujii T, Sugimoto H, Nomoto S, Nakao A. Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma. J Surg Oncol. 2011;104:814–21.View ArticlePubMedGoogle Scholar
  8. Sui C, Li B, Kan T, Yang J, Wu M. Safety and efficacy of trisectionectomy for hepatocellular carcinoma. ANZ J Surg. 2011;81:895–9.View ArticlePubMedGoogle Scholar
  9. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–7.View ArticlePubMedGoogle Scholar
  10. Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y, et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg. 2009;144:46–51.View ArticlePubMedGoogle Scholar
  11. Nobili C, Marzano E, Oussoultzoglou E, Rosso E, Addeo P, Bachellier P, et al. Multivariate analysis of risk factors for pulmonary complications after hepatic resection. Ann Surg. 2012;255:540–50.View ArticlePubMedGoogle Scholar
  12. Hiki N, Sano T, Nomura S, Nunobe S, Kumagai K, Aikou S, et al. Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol. 2014;21:891–8.View ArticlePubMedGoogle Scholar
  13. Luc G, Durand M, Chiche L, Collet D. Major post-operative complications predict long-term survival after esophagectomy in patients with adenocarcinoma of the esophagus. World J Surg. 2015;39:216–22.View ArticlePubMedGoogle Scholar
  14. Petermann D, Demartines N, Schäfer M. Severe postoperative complications adversely affect long-term survival after R1 resection for pancreatic head adenocarcinoma. World J Surg. 2013;37:1901–8.View ArticlePubMedGoogle Scholar
  15. House MG, Pitt HA, Nakeeb A, Howard TJ, Zyromski NJ, Schmidt CM, et al. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma. HPB (Oxford). 2011;13:139–47.Google Scholar
  16. Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JP, et al. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251:91–100.View ArticlePubMedGoogle Scholar
  17. Correa-Gallego C, Gonen M, Fischer M, Grant F, Kemeny NE, Arslan-Carlon V, et al. Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. Ann Surg Oncol. 2013;20:2477–84.View ArticlePubMedGoogle Scholar
  18. van der Gaag NA, Harmsen K, Eshuis WJ, Busch OR, van Gulik TM, Gouma DJ. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death. Eur J Surg Oncol. 2014;40:551–8.View ArticlePubMedGoogle Scholar
  19. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, et al. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med. 2003;31:1722–9.View ArticlePubMedGoogle Scholar
  20. Clerici M, Shearer GM, Clerici E. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. J Natl Cancer Inst. 1998;90:261–3.View ArticlePubMedGoogle Scholar
  21. Chau GY, Wu CW, Lui WY, Chang TJ, Kao HL, Wu LH, et al. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg. 2000;231:552–8.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Zhou YM, Shao WY, Zhao YF, Xu DH, Li B. Meta-analysis of laparoscopic versus open resection for hepatocellular carcinoma. Dig Dis Sci. 2011;56:1937–43.View ArticlePubMedGoogle Scholar
  23. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg. 1997;226:704–11.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Xia F, Lau WY, Xu Y, Wu L, Qian C, Bie P. Does hepatic ischemia-reperfusion injury induced by hepatic pedicle clamping affect survival after partial hepatectomy for hepatocellular carcinoma? World J Surg. 2013;37:192–201.View ArticlePubMedGoogle Scholar
  25. Zhou Y, Zhang X, Zhang Z, Liu X, Wu L, Li Y, et al. Hepatectomy in elderly patients: does age matter? World J Surg. 2013;37:2899–910.View ArticlePubMedGoogle Scholar
  26. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© Zhou et al. 2015

Advertisement